Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4Phase 1/2 1Phase 1 1

Status

Recruiting 2Active not recruiting 2Completed 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Neoplasms 1Gastric Cancer Adenocarcinoma Metastatic 1CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

pembrolizumab 512Specimen Handling 381Carboplatin 371Magnetic Resonance Spectroscopy 333Cisplatin 327Nivolumab 302Cyclophosphamide 295Radiotherapy 254Paclitaxel 252Biopsy 235Gemcitabine 229Bevacizumab 212Dexamethasone 167durvalumab 162Oxaliplatin 160Capecitabine 154Rituximab 151Fluorouracil 148venetoclax 142atezolizumab 141Docetaxel 141Drug Therapy 140Etoposide 138Doxorubicin 131Ipilimumab 125Radiosurgery 118Lenalidomide 117Prednisone 116Leucovorin 111fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × zolbetuximab × 1 year × Clear all
NCT03816163 2026-06-04

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Astellas Pharma Inc

Phase 2 Active not recruiting
393 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03505320 2026-04-03

ILUSTRO

Astellas Pharma Inc

Phase 2 Active not recruiting
143 enrolled
Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT06468280 2026-01-21

ROSETTE

Shanghai Zhongshan Hospital

Phase 2 Recruiting
84 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06962137 2025-12-22

RAINSPOT

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

NCT01630083 2025-06-15

FAST

Astellas Pharma Inc

Phase 2 Completed
252 enrolled
Gastrointestinal

CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡